Neomorph, Inc.
Neomorph is a clinical-stage biotech company developing molecular glue degraders to target previously undruggable disease drivers. The company has raised $209M in venture funding and employs 97 people.
The growth story
Neomorph, Inc. grew from 31 to 97 employees between 2021 and 2026, raising $209M along the way, most recently a Series B in April 2026.
About
Neomorph engineers protein surfaces to create molecular glue degraders, a new class of drugs that can target proteins involved in serious diseases that were previously considered untreatable. Their technology focuses on E3 ubiquitin ligases, enzymes that mark proteins for destruction.
The company has built the largest proprietary library of molecular glue targets since its 2020 founding. With $209M in funding from investors including Deerfield Management and Regeneron Ventures, Neomorph is advancing its pipeline through clinical trials.
Founders and leadership
Research is Neomorph's largest function, accounting for nearly half of its 97 employees. The company operates with a relatively flat structure typical of early-stage biotechs, with a median tenure of 2 years.
The Neomorph, Inc. org chart
Phil Chamberlain (Co-Founder, President and CEO) leads 34 mapped leaders with 14 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 56 (+6% YoY), Business Development 12 (+33% YoY), Engineering 6 (0% YoY), Operations 5 (+67% YoY), Accounting 3 (+50% YoY).
Talent flow
Neomorph recruits heavily from major pharma companies, with Bristol Myers Squibb and GNF being the top sources. Its workforce includes graduates from UC San Diego, UC Berkeley, and other California universities. Alumni have moved to Eli Lilly, Amgen, and other biopharma firms.
Most common previous employers of Neomorph, Inc. staff: Bristol Myers Squibb (13), GNF (13), Celgene (9), Scripps Research (9), Novartis (8), UC San Diego (7). Former Neomorph, Inc. employees most often moved to Eli Lilly and Company (3), Amgen (2), UC San Diego (2), Kiora Pharmaceuticals (1), Johnson & Johnson Innovative Medicine (1), Ipsen (1).
Alumni worth knowing
Hiring now
Web traffic
Traffic mix: 52% direct, 25% search, 16% social, 1% paid.
What this company is made of
Most common skills at Neomorph, Inc.: Research Skills (36), Molecular Biology (30), Drug Discovery (28), Cell Culture (27), Western Blotting (24), Biochemistry (24), Microsoft Office (24), Cell Biology (22).
Where the team actually sits
Neomorph, Inc. people are concentrated in California, United States (72), San Diego Metropolitan Area (5), United States (4), Greater Boston (2).
Search footprint
Neomorph, Inc. attracts about 799 organic search visits a month, traffic worth roughly $1K a month if bought through ads. It gained 16 ranking keywords and lost 11 in the last period.
What employees say
- Compensation
- 3.90 / 5
- Career opportunities
- 3.80 / 5
- Senior management
- 4.10 / 5
- Work-life balance
- 3.80 / 5
Frequently asked
Neomorph, Inc. has 97 employees as of September 2026.
Neomorph, Inc. has raised $209M in total, most recently a Series B round in April 2026.
Neomorph, Inc. was founded in 2020 by Eric Fischer, Phil Chamberlain.
Phil Chamberlain (Co-Founder, President and CEO) sits at the top of Neomorph, Inc.'s reporting structure, with 14 direct reports.
The most common previous employers of current Neomorph, Inc. staff are Bristol Myers Squibb (13 people), GNF (13 people), Celgene (9 people).
Former Neomorph, Inc. employees most often move to Eli Lilly and Company (3), Amgen (2), UC San Diego (2).
Neomorph, Inc. attracts about 799 organic search visits a month, worth roughly $1K a month in equivalent ad spend.
The most common skills among Neomorph, Inc. staff are Research Skills, Molecular Biology, Drug Discovery, Cell Culture, Western Blotting.
Neomorph, Inc. staff are concentrated in California, United States (72), San Diego Metropolitan Area (5), United States (4).
Neomorph, Inc. has about 56 people in Research, up 6% over the past year, as of September 2026.
Neomorph, Inc. has about 12 people in Business Development, up 33% over the past year, as of September 2026.
Computed from 84 current and 29 former Neomorph, Inc. profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.